Jon Grant, JD, MD, MPH

Professor, Department of Psychiatry and Behavioral Neuroscience

5841 S. Maryland Ave., MC 3077
Fax: 773- 834-6761

Website: http://acid.uchicago.edu/

Education & Training

  • B.A., 1986, University of Michigan
  • M.A., 1987, University of Chicago
  • J.D., 1992, Cornell University
  • M.D., 1999, Brown University
  • M.P.H., 1999, Harvard University
  • Residency, 1999-2003, Department of Psychiatry, University of Minnesota
  • Board Certified, American Board of Psychiatry and Neurology (Adult, General)
  • Board Certified, American Board of Addiction Medicine

Clinical Interests

  • Addictive, impulsive and compulsive disorders
  • Sexual disorders
  • Neuropsychopharmacology

Research Interests

  • Therapeutic interventions for impulsive-compulsive disorders
  • Neurocognitive correlates of impulsive-compulsive behavior
  • Neural basis of cognitive, emotional and behavioral dysfunction

Teaching

  • Addiction lectures, Psychiatry residency program, 2012-2013

Society Memberships

  • Fellow, American Psychiatric Association
  • Member, Society of Biological Psychiatry
  • Member, International Society for Research on Impulsivity and Impulse Control Disorders
  • Member, International College of Obsessive Compulsive Spectrum Disorders
  • Fellow, American Psychopathological Association
  • Member, American College of Psychiatrists
  • Member, American College of Neuropsychopharmacology

Selected Publications

  • Grant JE, Odlaug BL, Chamberlain SR, Keuthen NJ, Lochner C, Stein DJ. Skin picking disorder: an under-recognized and under-treated disorder.  Am J Psychiatry (in press)
  • Hodgins DC, Stea JN, Grant JE. 2011. Gambling disorders. The Lancet 378(9806):1874-84.
  • Grant JE, Odlaug BL, Potenza MN, Hollander E, Kim SW. 2010. Nalmefene in the treatment pathological gambling: multicentre, double-blind, placebo-controlled study. Br J Psychiatry 197:330-331
  • Grant JE, Oldaug BL, Kim SW. 2009. A double-blind, placebo-controlled trial of a glutamate modulating agent, N-acetyl cysteine, in the treatment of trichotillomania. Arch Gen Psychiatry 66(7): 756-763
  • Grant JE, Kim SW, Odlaug BL.2009. A double-blind, placebo-controlled trial of the opioid antagonist, naltrexone, in the treatment of kleptomania. Biol Psychiatry 65(7):600-606
  • Grant JE, Donahue CJ, Odlaug BL, Kim SW, Miller MJ, Petry NM. 2009. Imaginal desensitization plus motivational interviewing in the treatment of pathological gambling: a randomized controlled trial. Br J Psychiatry 195:266-267
  • Grant JE, Kim SW, Odlaug BL. 2007. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 62(6):652-657
  • Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A. 2006. A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303-312
  • Grant JE, Levine L, Kim D, Potenza MN. 2005. Impulse control disorders in adult psychiatric       inpatients. Am J Psychiatry 162:2184-2188

Selected Conferences & Presentations

  • Keynote. National Association for Gambling Studies of Australia. Cognition in gambling disorders. Melbourne, Australia. 2011
  • Keynote. National Gambling Association of Korea. Clinical treatment of pathological gambling. Seoul, South Korea. 2011
  • Keynote. Finnish Society of Addiction Medicine. Pathological gambling: neurobiology and pharmacological treatment. Turku, Finland. 2009
  • Keynote. Asian Pacific Problem Gambling and Addictions Conference.  Pharmacological management of pathological gambling. Hong Kong. 2008
  • ABC Primetime. Kleptomania. 2005
  • The Jane Pauley Show, NBC. Pathological gambling in women. 2005
  • CBS Early Show. Kleptomania. 2004
  • ESPN.  Pete Rose on Trial. 2003

Other Activities

  • Board Member, South African Responsible Gambling Foundation
  • International Advisory Panel for Addictions – Minister for Health - Singapore
  • Advisory Chair, Scientific Advisory Board, Trichotillomania Learning Center